← Open Payments lookup

DAWN TAMAGNI: Open Payments

NPI 1033299920 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$442 in 13 payments from 7 companies in 2025. Trend: 2023 $564 · 2024 $320 · 2025 $442

Food & beverage: $410Education: $32
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP1$110
Tandem Diabetes Care, Inc.2$96
Novo Nordisk Inc4$85
ABBVIE INC.2$60
Corcept Therapeutics2$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$25
Lilly USA, LLC1$19

Products named: AIRSUPRA, t:slim X2 Insulin Pump with Control-IQ, Rybelsus, Korlym, CREON, Ozempic, LINZESS, XIFAXAN.

Industry payments across ID — which companies pay providers there.